JANE STREET GROUP, LLC
Position in HRMY — Harmony Biosciences Holdings, Inc.
CIK 1595888
NEW YORK, NY
Position in HRMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
-$279,903 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
16 quarters on record
Common Shares in HRMY Over Time
Shares Held
Position Value (USD)
Derivatives in HRMY
reported options exposure · as of Jun 30, 2026CallValue
$1,776,808
CallShares
48,800
PutValue
$2,807,211
PutShares
77,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
2,934,193 | $218,538,693 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
191,541 | $102,847,939 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
403,995 | $98,885,855 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
1,752,646 | $96,290,370 | |
| 5 | EXEL |
Exelixis, Inc.
|
1,402,438 | $76,306,651 | |
| 6 | QURE |
uniQure N.V.
|
1,610,483 | $74,178,846 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
694,684 | $54,372,915 | |
| 8 | TVTX |
Travere Therapeutics, Inc.
|
938,699 | $53,327,489 |
All Filings in HRMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,776,808 | 48,800 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $2,807,211 | 77,100 | Put | Defined | 2026-08-14 | |
| 2026-03-31 | $2,347,238 | 83,800 | Call | Defined | 2026-05-12 | |
| 2026-03-31 | $279,903 | 9,993 | Shares | Defined | 2026-05-12 | |
| 2026-03-31 | $2,235,198 | 79,800 | Put | Defined | 2026-05-12 | |
| 2025-12-31 | $3,805,614 | 101,700 | Put | Defined | 2026-02-12 | |
| 2025-12-31 | $8,291,036 | 221,567 | Shares | Defined | 2026-02-12 | |
| 2025-12-31 | $2,016,938 | 53,900 | Call | Defined | 2026-02-12 | |
| 2025-09-30 | $3,103,999 | 112,627 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $1,719,744 | 62,400 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $1,433,120 | 52,000 | Call | Defined | 2025-11-14 | |
| 2025-06-30 | $1,409,360 | 44,600 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $1,128,858 | 34,012 | Shares | Defined | 2025-05-19 | |
| 2025-03-31 | $248,925 | 7,500 | Call | Defined | 2025-05-19 | |
| 2024-09-30 | $204,000 | 5,100 | Call | Defined | 2024-11-15 | |
| 2024-09-30 | $3,483,000 | 87,075 | Shares | Defined | 2024-11-15 | |
| 2024-06-30 | $3,374,151 | 111,838 | Shares | Defined | 2024-08-15 | |
| 2023-12-31 | $1,998,368 | 61,869 | Shares | Defined | 2024-02-15 | |
| 2023-09-30 | $2,941,008 | 89,747 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $717,699 | 20,395 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $2,515,355 | 77,040 | Shares | Defined | 2023-05-16 | |
| 2022-12-31 | $243,210 | 4,414 | Shares | Defined | 2023-02-15 | |
| 2022-09-30 | $577,097 | 13,030 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $301,105 | 6,174 | Shares | Defined | 2022-08-16 | |
| 2022-03-31 | $851,277 | 17,498 | Shares | Defined | 2022-05-17 | |
| No filing history on record for this holder in this stock. | ||||||